Accendra Health Receives NYSE Non-Compliance Notice
Accendra Health (ACH) announced on Friday that it has received a formal notice from the New York Stock Exchange regarding its failure to meet continued listing standards. The notification indicates that the company is currently in violation of specific regulatory requirements necessary to maintain its presence on the exchange. The company stated it plans to respond to the NYSE within 10 business days to affirm its intention to submit a formal business plan aimed at regaining compliance. This development follows recent corporate transitions, including the appointment of a new CEO.
Topics: listing standards NYSE non-compliance notice regulatory compliance
Read the full article at Seeking Alpha
Part of the story Annovis Bio Receives NYSE Non-Compliance Notice Due to Low Market Capitalization (2 articles)